SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MNDE is the governance token for Marinade. Marinade helps you to stake Solana without locking in liquidity by turning SOL into mSOL - tokenized version of staked SOL. This way you can both secure the network by staking SOL, and use your mSOL as the ultimate unit in Solana DeFi ecosystem. To provide liquidity, deposit in lending protocols and even buy NFTs.

Marinade

Marinade is seeing increased chatter as investors speculate on a breakout, with many in the community highlighting its significant total value locked relative to its market cap. Traders are actively tracking bullish technical patterns and potential institutional integration, viewing it as an undervalued play within the Solana ecosystem.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing significant volatility following a corporate rebranding and Nasdaq listing, with the community sharply divided between those optimistic about its upcoming Phase 2 generalized anxiety disorder data and Phase 3 major depressive disorder milestones and skeptics pointing to a history of dilution and management concerns. Investors are closely monitoring the company's capital runway and leadership changes while debating whether the stock's current valuation represents a distressed entry point for a potential acquisition or a continued downward trend.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is seeing increased investor focus due to a series of upcoming Phase 3 clinical readouts for its lead psychedelic pipeline and ongoing discussions regarding its strategic repositioning. While community sentiment remains divided over the firm's history of leadership changes and reverse splits, bulls are optimistic about the potential for breakthrough data to serve as a significant value catalyst.

Highstreet

Highstreet ($HIGH) is actively being monitored by traders as a high-volatility play, with the community analyzing whale accumulation patterns and comparing it to previous rapid surges. Despite concerns over volatility and price corrections, discussions remain polarized between those anticipating a major short squeeze and others expressing frustration with price action.

Daddy Darth Sidious

The community is actively debating a potential sector rotation among meme tokens, with traders closely monitoring price movements for opportunities to pivot between competing assets. Sentiment remains polarized as participants weigh the speculative nature of these tickers against aggressive attempts to drive volume and market interest.

Advisorshares Trust - AdvisorShares Psychedelics ETF

AdvisorShares Psychedelics ETF

Investors are actively debating the potential for long-term growth in the psychedelics sector, with many viewing current price levels as a deep-value opportunity despite ongoing volatility and concerns regarding fund management. The conversation is driven by optimism surrounding emerging clinical trial data, potential regulatory shifts, and the long-term role of these companies in the evolving mental health landscape.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva is trending following a strong quarterly earnings report that beat expectations, fueled by double-digit growth in its branded innovative portfolio, specifically the Austedo franchise. Investors are focused on the company's successful 'Pivot to Growth' strategy, with community discussion centering on continued debt deleveraging, upwardly revised sales guidance, and active institutional buying following several credit rating upgrades.

Rewarding holding and rejecting the culture of fast flips. Longterm sustainability by using a multi-phase dynamic rewards system. Meme that inspires creativity and innovation. Fun community involvement, including games, memes, and also serious holder mindset. We have automated rewards to holders, buyback and burns and are giving back to ocean cleanup initiatives. All pump fun creator rewards are used for the buyback and burn of the token, rewarding holders, and donating to nonprofits that clean our oceans.

MAKE HOLDING GREAT AGAIN

MHGA is gaining momentum on the Solana blockchain, driven by its recent listing on major platforms and a unique rewards structure that distributes dividends to long-term holders. The community is actively discussing the project's utility, including its charity initiatives and the passive income potential provided by its creator fee mechanism.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor ($TAO) is trending as the community debates its long-term potential as a 'Bitcoin of AI' amidst volatility triggered by a major subnet operator leaving the network. While some investors fear centralization and governance issues, others are actively accumulating, viewing the recent price swings as a 'buy the fear' opportunity to gain exposure to the growing decentralized AI infrastructure.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate as the token's massive appreciation sparks accusations of an orchestrated pump-and-dump scheme. While proponents highlight upcoming global event partnerships and a unique Web3-music narrative, critics and on-chain analysts are pointing to high supply concentration and warning of potential market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
